share_log

HC Wainwright & Co. Maintains Buy on KemPharm, Lowers Price Target to $10

HC Wainwright & Co. Maintains Buy on KemPharm, Lowers Price Target to $10

HC Wainwright & Co.维持KempHarm的买入,将目标价下调至10美元
Benzinga Real-time News ·  2022/08/17 06:40

HC Wainwright & Co. analyst Oren Livnat maintains KemPharm (NASDAQ:KMPH) with a Buy and lowers the price target from $11 to $10.

HC Wainwright & Co. 分析师奥伦·利夫纳特维持KemPharm(纳斯达克股票代码:KMPH)的买入并将目标股价从11美元下调至10美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发